Primary PTCA versus thrombolysis with tPA in acute myocardial infarction: A formal cost-effectiveness analysis

Wiener Klinische Wochenschrift

Volumn 111, Issue 1, 1999, Pages 37-41

  Müllner, Marcus ^a   Paulis, Monika ^a   Nikfardjam, Mariam ^a   Domanovits, Hans ^a   Huber, Kurt ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Acute myocardial infarction; Cost effectiveness; Percutaneous transluminal coronary angioplasty; Thrombolysis; tPA

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; AUSTRIA; COST EFFECTIVENESS ANALYSIS; DRUG COST; FIBRINOLYTIC THERAPY; HEALTH CARE COST; HUMAN; PUBLIC HEALTH INSURANCE; REIMBURSEMENT; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COST-BENEFIT ANALYSIS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0344177517     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Lieu TA, Gurley RJ, Lundstrom RJ, Parmley WW (1996) Primary angioplasty and thrombolysis for acute myocardial infarction: an evidence summary. J Am Coll Cardiol 27: 737-750
2. Every NR, Parsons LS, Hlatky M, Martin JS, Weaver WD, for the Myocardial Infarction Triage and Intervention Investigators (1996) A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. N Engl J Med 335: 1253-1260
3. Lange RA, Hillis LD (1996) Should thrombolysis or primary angioplasty be the treatment of choice for acute myocardial infarction? Thrombolysis - the preferred treatment. N Engl J Med 335:1311-1312, 1316-1317
4. Grines CL (1996) Should thrombolysis or primary angioplasty be the treatment of choice for acute myocardial infarction? Primary angioplasty - the strategy of choice. N Engl J Med 335: 1313-1316, 1316-1317
5. Michels KB, Yusuf S (1995) Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation 91: 476-485
6. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO lib) Angioplasty Substudy Investigators (1997) A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 336: 1621-1628
7. Grines CL, Browne KF, Marco J et al for the Primary Angioplasty in Myocardial Infarction Study Group (1993) A comparison of immediate coronary angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 328: 673-679
8. Zijlstra F, de Boer MJ, Beukema WP et al (1996) Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction. Eur Heart J 17: 382-387
9. Gibbons RJ, Holmes DR, Reeder GS et al for the Mayo Coronary Care Unit and Catheterization Laboratory Groups (1993) Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 328: 685-691
10. Stone GW, Grines CL, Rothbaum D, et al for the PAMI Trial Investigators (1997) Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the primary angioplasty in myocardial infarction (PAMI) trial. J Am Coll Cardiol 29: 901-907
11. Lansky AJ, Saucedo J, Thompson C. Abizaid AS, Mehran R. Popma JJ (1997) Ninth Annual Transcatheter Cardiovascular Therapeutics Syllabus (September 24-28, 1997, Washington, DC)
12. Neuhaus KL, Feuerer W, Jeep-Tebbe S, et al (1989) Improved thrombolysis with a modified dose regimen of recombinant tissue type plasminogen activator. J Am Coll Cardiol 14: 1566-1569
13. Nichol G, Hallstrom AP, Ornato JP et al (1998) Potential cost-effectiveness of public access defibrillation in the United States. Circulation 97: 1315-1320
14. Mikhail MG, Smith FA, Gray M, et al (1997) Cost-effectiveness of mandatory stress testing in chest pain center patients. Ann Emerg Med 29: 88-98
15. Bur A, Müllner M, Sterz F, et al (1997) The emergency department in a 2000-bed teaching hospital: saving open ward and intensive care facilities. Eur J Emerg Med 4: 19-23
16. Nikfardjam N, Schreiber W. Müllner M, et al (1998) Prognose des akuten Myokardinfarktes in der Ära der systemischen Thrombolyse: Beschreibung einer nichtselektierten Kohorte von 1084 Patienten. Wien Klin Wochenschr 110: 31
17. Mark DB, O'Neill WW, Brodle B, et al (1995) Baseline and 6-months cost of primary angioplasty therapy for acute myocardial infarction: results from the primary angioplasty registry. J Am Coll Cardiol 26: 688-695
18. Cohen DJ, Krumholz HM, Sukin CA, et al for the Stent Restenosis Study Investigators (1995) In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Circulation 92: 2480-2487